Opportunity Information: Apply for CDC RFA DP13 131104CONT16
Apply for CDC RFA DP13 131104CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Standardizing Electronic Laboratory and Biomarker Reporting" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283.
- This funding opportunity was created on Feb 22, 2016 and posted on Feb 22, 2016.
- Applicants must submit their applications by Apr 22, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Standardizing Electronic Laboratory and Biomarker Reporting" is a continuation funding announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is published under Funding Opportunity Number CDC RFA DP13 131104CONT16 and is categorized as a health-related program under CFDA 93.283. The central purpose, as stated in the opportunity description, is to support work that advances the standardization of electronic reporting for laboratory results and biomarker data. In practical terms, this type of initiative generally focuses on making lab and biomarker information more consistent and interoperable when it moves electronically between laboratories, healthcare providers, public health agencies, and other authorized partners, which can improve data quality and usability for surveillance, research, and public health decision-making.
The funding mechanism is a cooperative agreement, which typically indicates that the CDC expects to have substantial involvement in the project beyond simply providing funds. Cooperative agreements often involve close collaboration with the agency on technical direction, alignment to national standards, and coordination with broader public health data modernization efforts. The opportunity is explicitly labeled as a continuation award, meaning it is intended to extend or continue an existing project or previously funded work rather than launch a brand-new, open competition. This context usually implies that activities are building on established partnerships, ongoing implementations, or previously developed infrastructure related to electronic reporting and standard use.
Key administrative details include an original and current closing date of April 22, 2016, with a creation and posting date of February 22, 2016. The award ceiling is listed as 0, and the expected number of awards is not specified in the provided source data. A listed ceiling of 0 in some federal postings can reflect that the exact funding level is determined through continuation terms, depends on appropriations and negotiated budgets, or is otherwise not publicly stated in the notice summary. Eligibility is not broadly defined in the summary field and is instead referenced as "Others" with additional clarification expected in a separate eligibility section of the full announcement, which commonly occurs with continuation opportunities where eligible applicants may be limited to current recipients or a defined set of partners.
Overall, the opportunity is best understood as CDC support for continuing efforts to improve how laboratory and biomarker information is captured and transmitted electronically in standardized formats. This kind of work typically aims to reduce variation across systems, enable more reliable data exchange, and strengthen the ability of public health and healthcare organizations to aggregate and interpret laboratory-related information for monitoring health outcomes, tracking disease trends, and supporting timely public health responses.
Frequently Asked Questions (FAQs): Standardizing Electronic Laboratory and Biomarker Reporting
1) What is the title of this grant opportunity?
The opportunity is titled "Standardizing Electronic Laboratory and Biomarker Reporting."
2) Which federal agency is offering this opportunity?
This is a funding opportunity from the U.S. Department of Health and Human Services (HHS), specifically the Centers for Disease Control and Prevention (CDC).
3) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA DP13 131104CONT16.
4) What program area or topic does this funding support?
It is categorized as a health-related program. The stated purpose is to support work that advances the standardization of electronic reporting for laboratory results and biomarker data.
5) What is the CFDA number for this opportunity?
The CFDA listing provided is 93.283.
6) What is the main purpose of the grant, in plain language?
The central purpose is to help make laboratory and biomarker information more consistent and interoperable when it is transmitted electronically between laboratories, healthcare providers, public health agencies, and other authorized partners. This can improve data quality and usability for things like surveillance, research, and public health decision-making.
7) What types of improvements is this funding generally trying to achieve?
Based on the opportunity description, this kind of effort generally aims to:
- Reduce variation in how lab and biomarker results are represented across systems
- Support standardized electronic formats that enable reliable data exchange
- Improve aggregation and interpretation of lab-related information for monitoring health outcomes and disease trends
- Strengthen timely public health responses by improving data flow and usability
8) What is the funding mechanism?
The funding mechanism is a cooperative agreement.
9) What does it mean that this is a cooperative agreement?
A cooperative agreement typically means the CDC expects to have substantial involvement in the project beyond providing funds. In practice, this often includes collaboration on technical direction, alignment to national standards, and coordination with broader public health data modernization efforts.
10) Is this an open competition for new projects?
No. It is explicitly labeled as a continuation award. That means it is intended to extend or continue existing work rather than start a brand-new, broadly open competition.
11) What does "continuation award" imply about the expected activities?
A continuation award typically implies the work is building on previously funded activities, such as established partnerships, ongoing implementations, or infrastructure already developed for electronic reporting and standards-based data exchange.
12) Who is eligible to apply?
The summary field does not provide broad eligibility details. It lists eligibility as "Others" and indicates that additional clarification would be expected in the full announcement's eligibility section. For continuation opportunities, eligibility is often limited to current recipients or a defined set of partners, but the specific limitation is not stated in the provided summary.
13) What are the key dates listed for this opportunity?
- Posting (creation) date: February 22, 2016
- Closing date: April 22, 2016 (original and current closing date are the same)
14) What is the application deadline?
The listed closing date is April 22, 2016.
15) What is the award ceiling?
The award ceiling is listed as 0 in the provided data.
16) Does an award ceiling of 0 mean there is no funding?
Not necessarily. In some federal postings, a ceiling of 0 can indicate that the funding level is not publicly stated in the summary, is determined through continuation terms, depends on appropriations, or is otherwise handled through negotiated budgets for continuation awards.
17) How many awards will be made?
The expected number of awards is not specified in the provided source data.
18) What kinds of organizations or partners might be involved in this type of work?
The description references electronic movement of data between laboratories, healthcare providers, public health agencies, and other authorized partners. The opportunity does not list specific applicant types in the summary beyond "Others."
19) Why is standardizing lab and biomarker reporting important?
According to the opportunity description, standardization can help ensure data is more consistent and interoperable, which improves the ability of health and public health organizations to use lab-related information for surveillance, research, and public health decision-making, including monitoring outcomes, tracking trends, and supporting timely response.
20) What is the overall goal of the continued CDC support described here?
Overall, the opportunity is best understood as CDC support for continuing efforts to improve how laboratory and biomarker information is captured and transmitted electronically in standardized formats, with the intention of strengthening data exchange and the usefulness of the resulting information for public health.
Browse more opportunities from the same category: Health
Next opportunity: Integrating Human Health and Well-Being with Ecosystem Services
Previous opportunity: Office of Postsecondary Education (OPE): Asian American and Native American Pacific Islander-Serving Institutions Program CFDA Number 84.382B
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP13 131104CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP13 131104CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| The Prevention and Control of Unintentional Injury and Violence Prevention Through the World Health Organization Apply for CDC RFA CE16 1601 Funding Number: CDC RFA CE16 1601 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| PPHF16: Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke – Financed Solely by 2016 Prevention and Public Health Funds Apply for CDC RFA DP14 142203PPHF16 Funding Number: CDC RFA DP14 142203PPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Modeling of Infectious Disease Agent Study Research Projects (R01) Apply for PA 16 107 Funding Number: PA 16 107 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Evidence-Based Falls Prevention Programs in Tribal Communities Financed Solely by 2016 Prevention and Public Health Funds (PPHF-2016) Apply for HHS 2016 ACL AOA FP 0133 Funding Number: HHS 2016 ACL AOA FP 0133 Agency: HHS-ACL Category: Health Funding Amount: $150,000 |
| Enhancing Cancer Registries for Early Case Capture of Pediatric and Young Adult Cancer Cases Apply for CDC RFA DP14 140203CONT16 Funding Number: CDC RFA DP14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Developmental Behavioral Pediatrics Research Network Apply for HRSA 16 039 Funding Number: HRSA 16 039 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Biomarkers Discovery In Parkinsonism (U01) Apply for PAR 16 112 Funding Number: PAR 16 112 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National Organizations’ Support for State Oral Health Programs Apply for CDC RFA DP13 131304CONT16 Funding Number: CDC RFA DP13 131304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Characterization of Circulating Pro- and Anti-Geronic Proteins and Peptides (R01) Apply for RFA AG 17 002 Funding Number: RFA AG 17 002 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34) Apply for PAR 16 113 Funding Number: PAR 16 113 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships Apply for CDC RFA DD14 140303CONT16 Funding Number: CDC RFA DD14 140303CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Center without Walls for the Identification and Validation of Molecular Mechanisms Contributing to Tau Pathogenesis and Associated Neurodegeneration in Frontotemporal Degeneration (FTD) (U54) Apply for RFA NS 16 023 Funding Number: RFA NS 16 023 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| Empowering Older Adults and Adults with Disabilities in Tribal Communities through Chronic Disease Self-Management Education Programs Financed Solely by 2016 Prevention and Public Health Funds (PPHF-2016) Apply for HHS 2016 ACL AOA CS 0129 Funding Number: HHS 2016 ACL AOA CS 0129 Agency: HHS-ACL Category: Health Funding Amount: $150,000 |
| Cooperative Study Group for Autoimmune Disease Prevention (U01) Apply for RFA AI 16 003 Funding Number: RFA AI 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: $1,600,000 |
| Stimulating Peripheral Activity to Relieve Conditions (SPARC): Pre-clinical Development of Existing Market-approved Devices to Support New Market Indications (U18) Apply for RFA RM 16 009 Funding Number: RFA RM 16 009 Agency: HHS-NIH11 Category: Health Funding Amount: $400,000 |
| Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Apply for CDC RFA DD15 150702CONT16 Funding Number: CDC RFA DD15 150702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Chinese Center for Disease Control and Prevention Apply for CDC RFA GH12 124705CONT16 Funding Number: CDC RFA GH12 124705CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir (R01) Apply for PAR 16 115 Funding Number: PAR 16 115 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Addiction Technology Transfer Center: Networking Coordinating Office for Internationally-based Addiction Technology Transfer Centers (Short Title: Global-ATTC) Apply for TI 16 015 Funding Number: TI 16 015 Agency: HHS-SAMHS Category: Health Funding Amount: $100,000 |
| Small Vessel Vascular Contributions to Cognitive Impairment and Dementia (VCID) Biomarkers Consortium: Coordinating Center (U24) Apply for RFA NS 16 019 Funding Number: RFA NS 16 019 Agency: HHS-NIH11 Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP13 131104CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.